2Zhang Y, Kaminski N. Biomarkers in idiopathic pulmo- nary fibrosis[J]. Curr Opin Pulm Meg ,2012,18(5): 441-446.
3Huang H, Peng X, Nakajima J. Advances in the study of biomarkers of idiopathic pulmonary fibrosis in Japan[J]. Biosci Trends ,2013,7(4) : 172-177.
4Kohno N, Akiyama M, Kyoizumi S, et al: Detection of soluble tumor-associated antigens in sera and effu- sions using novel monoclonal antibodies, KL-3 and KL- 6, against lung adenocarcinoma[J]. Jpn J Clin Oncol, 1988,18(3) :203-216.
5Samukawa T, Hamada T, Uto H, et al: The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfac- rant protein-D[J]. BMC Pulmonary Medicine, 2012, 12(55) 1471-2466.
6Kobayashi J, Kitamura S. KL-6 :a serum marker for in- terstitial pneumonia [J]. Chest, 1995, 108 (8): 311- 315.
7Ohshimo S, Ishikawa N, Horimasu Y, et al: Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis [J]. Respir Med, 2014, 108(7) : 1031-1039.
8Yanoa M, Sasakia H, Moriyamaa S, et al: Post-opera- tive acute exacerbation of pulmonary fibrosis in lung cancer patients undergoing lung resection[J]. Interact Card iovasc Thorae Su rg ,2012,14(2) 146-150.
9Kishaba T, Tamaki H, Shimaoka Y, et al: Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis[,J]. Lung, 2014,192 ( 1 ) : 141-149.
10Kohno N, Akiyama M, Kyoizumi S, et al: Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, a- gainst lung adenocarcinoma [J]. Jpn J Clin Oncol , 1998,18 (3) : 203-216.
8Kobayashi J,Kitamura S.KL-6:a serum marker for interstitial pneumonia.Chest,1995,108:311-315.
9Yokoyama A,Kohno N,Hamada H,et al.Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis.Am J Respir Crit Care Med,1998,158 (5 Pt 1):1680-1684.
10American Thoracic Society.Idiopathic pulmonary fibrosis:diagnosis and treatment.International consensus statement.American Thoracic Society (ATS),and the European Respiratory Society (ERS).Am J Respir Crit Care Med,2000,161 (2 Pt 1):646-664.
